Medical Crossfire®

Medical Crossfire®: The Advancing Role of Immunomodulatory Therapies in Modern Medicine

Advances In&trade;

Advances In™ Choroideremia&mdash;Evaluating the Potential of Gene Therapy on the Horizon

Clinical Consultations™

Clinical Consultations: Treating T2DM in the Modern Era: Right Patient, Right Treatment, Right Time

Clinical Consultations™: Coordinating Care Between the Pulmonologist and Rheumatologist in Systemic Sclerosis-Interstitial Lung Disease

Enduring Activity

Uncovering New Multiple Myeloma Therapies and their Clinical Applications: Antibodies, CARs, BiTEs, and Beyond

Virtual Coffee Talk: Let's Talk About Best Practices for Neutropenia Management Today, With an Eye Toward Bridging Clinical Gaps Tomorrow!

Advances In™ Cholangiocarcinoma: The Emerging Role of Immunotherapeutic and Targeted Approaches

Advances In™ Pancreatic Cancer: Expert Recommendations on Treating Metastatic Disease

Medical Crossfire®: An NP's and PA's Guide to Actinic Keratosis Treatment: Utilizing A Shared Decision-Making Process to Improve Patient Outcomes

Oncology Journal

Emergence of HIF inhibitors in Renal Cell Carcinoma

Online Activities

HER2/3 Across Solid Tumors: Toward Harmonization of Pathology and Oncology to Optimize Diagnosis and Management

Community Practice Connections™

Community Practice Connections™: 19th Annual International Congress on the Future of Breast Cancer®

<h2 style="text-align:center">Clinical Updates on the Rapid Advancements in COVID-19 Care: Vaccine Uptake and the Retail Pharmacist</h2>

<div style="text-align:center">An Online CE-accredited Article! 
&nbsp;</div>

<div style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px; text-align:center">This activity is supported by an educational grant from 
Janssen Therapeutics, Division of Janssen Products, LP.</div>
 
Faculty 
 
Miranda Wilhelm, PharmD 
Clinical Professor 
SIUE School of Pharmacy 
Department of Pharmacy Practice 
Edwardsville, Illinois 
 
Medical Reviewer 
 
Mary Barna Bridgeman, PharmD, BCPS, BCGP 
Clinical Professor 
Ernest Mario School of Pharmacy 
Rutgers, The State University of New Jersey 
Piscataway, New Jersey 
&nbsp;
<div style="margin-bottom:8pt; margin-left:0in; margin-right:0in; margin-top:0in; text-align:center">
<hr /></div>
 
Program Description 
The global COVID-19 pandemic has led to an unprecedented strain on the US health care system, and its rapid spread continues to pose a national threat, as it has climbed to the third leading cause of death in the United States after heart disease and cancer. The limited treatment options for COVID-19, coupled with its high rate of transmission, contribute to the large number of people infected and resultant morbidity and mortality. A global initiative is underway to develop a safe and effective COVID-19 vaccine. As frontline health care professionals, pharmacists will likely be involved in ensuring vaccine access and it&rsquo;s administration. Vaccine hesitancy is a long-standing health care issue and has only grown due to misinformation related to COVID-19. This educational activity will provide pharmacists with an understanding of the reasons for vaccine hesitancy as well as an in-depth review of the status of efforts to develop a COVID-19 vaccine including considerations for storage, administration, and adverse effect monitoring. 
 
Target audience:&nbsp;Retail pharmacists &nbsp; 
Type of activity:&nbsp;Knowledge 
Release date: January 13, 2021 
Expiration date: February 13, 2022 
Time to complete activity: 2.0 hours 
Fee: Free 
 
Educational Objectives 
At the completion of this activity, participants will be able to: 

<ul>
	<li>Describe the public health burden of COVID-19 and challenges in treatment and prevention</li>
	<li>Review the types of vaccines in development, their efficacy and safety, and the anticipated market launch timeline</li>
	<li>Recognize the role of the pharmacist and pharmacies in delivering COVID-19 vaccines to the population and in implementing strategies to overcome barriers and reduce vaccine hesitancy</li>
</ul>
 
<img alt="acpe" src="https://ptce.s3.amazonaws.com/_media/_eblast/ACPE_Large.jpg" style="float:left; height:59px; width:60px" />&nbsp;Pharmacy Times&nbsp;Continuing Education&trade; is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEU) under the ACPE universal activity number 0290-0000-21-001-H06-P. The activity is available for CE credit through February 13, 2022. 
 
 
Instructions for Completing the Activity and Receiving CPE Credit 
To receive CPE credit, participants must complete the pretest, view the webcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date. 
&nbsp;
<hr /> 
Disclosures 
 
Miranda Wilhelm, PharmD, has no relevant financial relationships with commercial interests to disclose. 
 
 
Mary Barna Bridgeman, PharmD, BCPS, BCGP, has the following relevant financial relationship with a commercial interest to disclose: 
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Speakers Bureau: AstraZeneca 
 
Pharmacy Times&nbsp;Continuing Education&trade;&nbsp;Planning Staff&nbsp;&ndash; Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Rose Namissa, PharmD, BCPS; Brianna Schauer, MBA, PMP; Susan Pordon; and Brianna Winters have no relevant financial relationships with commercial interests to disclose. 
 
An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose. 
 
Educational Disclaimer 
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources. 
 
For questions about this internet CPE activity, please contact: 
<a href="mailto:ceinfo@pharmacytimes.com">ceinfo@pharmacytimes.com</a> 
Privacy Policy and Terms of Use Information: 
<a href="http://www.pharmacytimes.org/terms">www.pharmacytimes.org/terms</a> 
&nbsp;

Clinical Updates on the Rapid Advancements in COVID-19 Care: Vaccine Uptake and the Retail Pharmacist